[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Webmail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 25, Issue 1 (Spring 2015) ::
MEDICAL SCIENCES 2015, 25(1): 16-26 Back to browse issues page
Effect of silymarin on estradiol valerate- induced polycystic ovary syndrome
Mohammad Nabiuni 1, Parvin Kayedpoor2 , Shima Mohammadi2 , Latifeh Karimzadeh3
1- of Cellular and Developmental Biology, Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran , devbiokharazmi@gmail.com
2- MSc Student in Cellular and Developmental Biology, Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
3- MSc in Cellular and Developmental Biology, Laboratory’s Animal Center and Cellular and Molecular Research Laboratory, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
Abstract:   (8160 Views)
Background: Polycystic ovary syndrome (PCOS) is the most common cause of infertility and endocrinopathy in women due to lack of ovulation. Silymarin has anti-inflammatory properties and is a modulator of the immune system. In this experimental study, the effect of silymarinon PCOS-induced rats was studied.
Materials and methods: In this experimental study, 144 adult Wistar rats were divided into groups of control, sham, PCOS (S.C. injection of 2mg estradiol valerate/ rat, once) and treated with silymarin. After induction of PCOS during 60 days, 20, 50, 100, 200 and 300 mg/kg BW silymarin was injected intraperitoneally for 10 days. Sham and control groups received DMSO and no injection, respectively. All groups were anesthetized and the serum and ovary of groups were collected in order to investigate the histological and serologic changes. Data were tested using ANOVA in Instat software and P <0.05 was considered significant.
 Results: PCOs induction resulted in elevation of follicular cyst formation, abnormal follicular development and increasing of androgen compared with control rats. Silymarin attenuated ovarian cysts and thickness of theca layer and improved hormonal balance and follicle development in PCOS rats.
Conclusion: Silymarin can reduce the histological and hormonal symptoms of PCOS, and has a protective effect on ovary. It seems that this potency is due to the antioxidant and anti-inflammatory effects of silymarin, which can reduce cyst counts and improve the development of ovarian follicles.
Keywords: Estradiol, Corpus luteum, PCOS, Silymarin
Full-Text [PDF 431 kb]   (6510 Downloads)    
Semi-pilot: Experimental | Subject: Molecular Biology
Received: 2015/03/9 | Accepted: 2015/03/9 | Published: 2015/03/9
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nabiuni M, Kayedpoor P, Mohammadi S, Karimzadeh L. Effect of silymarin on estradiol valerate- induced polycystic ovary syndrome. MEDICAL SCIENCES 2015; 25 (1) :16-26
URL: http://tmuj.iautmu.ac.ir/article-1-900-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 25, Issue 1 (Spring 2015) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.06 seconds with 37 queries by YEKTAWEB 4645